PharmaCyte Biotech's total assets for Q1 2027 were $36.71M, a decrease of -21.48% from the previous quarter. DE:EFYA total liabilities were $6.90M for the fiscal quarter, a -41.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.